Regencell Bioscience Holdings Ltd RGC Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$9.59 up $0.07, 0.74% at close Oct 16
Last close · Previous close $9.52
- Market cap
- At the Oct 16 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$9.59up $0.07, 0.74%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$9.52Oct 15
- Volume688.21KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume301.65KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $4.51 to $69.00; now $9.59
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
RGC beat the S&P 500 in 4 of 6 periods.
| Period | RGC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | RGC: up 68.8% S&P 500: up 1.5% | RGC beat the S&P 500 by 67.3 percentage points Beat |
| 3M | RGC: up 100.6% S&P 500: up 1.9% | RGC beat the S&P 500 by 98.7 percentage points Beat |
| YTD | RGC: down 54.3% S&P 500: up 12.8% | RGC trailed the S&P 500 by 67.1 percentage points Trailed |
| 1Y | RGC: down 46.6% S&P 500: up 16.8% | RGC trailed the S&P 500 by 63.4 percentage points Trailed |
| Long term | ||
| 3Y | RGC: up 2,163.5% S&P 500: up 81.5% +182.9% vs +22.0% a year | RGC beat the S&P 500 by 2,082.0 percentage points Beat |
| 5Y | RGC: up 1,855.0% S&P 500: up 83.1% +81.2% vs +12.9% a year | RGC beat the S&P 500 by 1,771.9 percentage points Beat |
$10,000 invested in RGC 5 years ago (Oct 15, 2021) would be worth about $195,504 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $18,305.
RGC beat the S&P 500 in 4 of 6 periods.
| Period | RGC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | RGC: up 68.8% S&P 500: up 1.2% | RGC beat the S&P 500 by 67.6 percentage points Beat |
| 3M | RGC: up 100.6% S&P 500: up 1.7% | RGC beat the S&P 500 by 98.9 percentage points Beat |
| YTD | RGC: down 54.3% S&P 500: up 11.9% | RGC trailed the S&P 500 by 66.2 percentage points Trailed |
| 1Y | RGC: down 46.6% S&P 500: up 15.5% | RGC trailed the S&P 500 by 62.1 percentage points Trailed |
| Long term | ||
| 3Y | RGC: up 2,163.5% S&P 500: up 75.0% +182.9% vs +20.5% a year | RGC beat the S&P 500 by 2,088.5 percentage points Beat |
| 5Y | RGC: up 1,855.0% S&P 500: up 71.2% +81.2% vs +11.4% a year | RGC beat the S&P 500 by 1,783.8 percentage points Beat |
$10,000 invested in RGC 5 years ago (Oct 15, 2021) would be worth about $195,504 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $17,118.
All-time high
$78.00
Closing high on . Now 87.7% below that record.
Split-adjusted daily closes since Jul 16, 2021.
Stock splits
1
38-for-1 on . One share bought before the first split is 38 shares today.
Valuation
Financials
About Regencell Bioscience Holdings Ltd
For more than 30 years, the TCM Practitioner whom Regencell partners with has treated patients with neurological disorders and infectious diseases. The TCM Practitioner’s TCM formulae candidates are derived from a TCM base formula and an adjustable formula which is developed based on his TCM brain theory, known as the “Sik-Kee Au TCM Brain Theory®”. Both Regencell and the TCM Practitioner are committed in giving back to the society and demonstrates its CARE through C aring for patients, A ccountability by maintaining a high standard of quality and integrity, R espect by valuing partnerships, teamwork and harmony and the E nthusiasm to improve the life of the underprivileged. Since its listing, Regencell through a joint venture with Honor Epic Enterprises Limited, formed Regencell Bioscience Asia Limited to offer COVID-19 related treatments to patients in ASEAN countries, India, Japan, Australia and New Zealand, as Regencell aspires to be the global market leader for the provision of natural and holistic treatment for neurological disorders and infectious diseases.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
RGC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
RGC stock FAQ
What is RGC stock’s price today?
Regencell Bioscience Holdings (RGC) traded at $9.59 at the close on , up $0.07 (0.74%) from the previous close of $9.52. Over the past 52 weeks it has traded between $4.51 and $69.00.
If you invested $1,000 in RGC 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in RGC on would be worth about $19,550 at the close on , a total return of +1,855.0%. The same $1,000 would be worth $534 if invested one year ago. Past performance doesn’t predict future returns.
Does RGC pay a dividend?
Regencell Bioscience Holdings hasn’t paid a dividend in the last twelve months.
What is RGC’s 52-week high and low?
Over the past 52 weeks RGC has traded as low as $4.51 and as high as $69.00. At $9.59 at the close on , it is 86.1% below that high and 112.6% above the low.
What is RGC’s all-time high?
RGC’s highest closing price was $78.00 on , adjusted for stock splits. At $9.59 at the close on , it is 87.7% below that record.
Has RGC stock ever split?
Yes, once: 38-for-1 on . One share bought before the first split would be 38 shares today.
How has RGC stock performed?
Including dividends and measured to the close on , RGC has returned −54.3% so far this year and −46.6% over the past year, and +1,855.0% over five years (+81.2% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What exchange does RGC trade on?
Regencell Bioscience Holdings trades on the Nasdaq under the ticker symbol RGC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.